Ethical Issues in Biotechnology — Current Affairs 2026

Current Affairs Connections

Recent developments and news linked to Ethical Issues in Biotechnology.

UK Approves Gene-Edited Crops for Commercial Cultivation (2024)

Early 2024

The UK's decision to approve gene-edited crops, distinct from traditional GMOs in regulatory terms, sparks renewed debate on food security, environmental impact, and consumer acceptance. This move, following Brexit, allows for faster development and commercialization of crops modified using techniques like CRISPR-Cas9. Ethically, it raises questions about the definition of 'natural,' the precautionary principle, and the potential for gene-edited organisms to impact biodiversity and agricultural ecosystems. For UPSC, this highlights the evolving global regulatory landscape and the ethical balancing act between innovation and caution in agricultural biotechnology.

UPSC Angle: GS-3 (Science & Technology - gene editing, agriculture, environmental impact); GS-4 (Ethics - precautionary principle, food ethics, regulatory ethics).

WHO Releases New Ethical Framework for AI in Health (2025)

Late 2025 (Predicted)

As Artificial Intelligence increasingly integrates with biotechnology, particularly in drug discovery, diagnostics, and personalized medicine, the World Health Organization (WHO) is anticipated to release updated or expanded ethical guidelines. This framework would address issues like algorithmic bias in genetic risk prediction, data privacy in AI-driven genomic analysis, accountability for AI errors in medical decisions, and equitable access to AI-powered biotech solutions. The convergence of AI and biotech presents novel ethical challenges that require proactive global governance, impacting how genetic data is used and how medical interventions are designed and delivered.

UPSC Angle: GS-3 (Science & Technology - AI, biotechnology, health); GS-4 (Ethics - AI ethics, data ethics, health equity, accountability).